No other industry faces the intersection of regulatory scrutiny and operational complexity quite like pharma and life sciences. Batch traceability from API to finished dose, serialisation and track-and-trace for anti-counterfeiting, GMP documentation across multi-site manufacturing, cold chain management for biologics and vaccines, clinical trial supply planning, and continuous compliance with CDSCO, US FDA, EU GMP, and Schedule M — these are not edge cases. They are daily operational realities.